On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

University of Gdańsk

InstitutionResearch output, impact & collaborations

University of Gdańsk is a institution indexed in ScholarIQ from OpenAlex.

What is known about University of Gdańsk?

ScholarIQrecord summary

University of Gdańsk is a research organisation in Gdansk, PL. OpenAlex records 42,447 works and 1,187,149 citations for it. 7,420 researchers list it as their most recent affiliation.

How many works does University of Gdańsk have?

ScholarIQindexed works

University of Gdańsk has 42,447 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does University of Gdańsk have?

ScholarIQcitation count

University of Gdańsk has 1,187,149 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at University of Gdańsk?

ScholarIQresearcher count

University of Gdańsk has 7,420 researchers in the ScholarIQ index.

What is the average h-index at University of Gdańsk?

ScholarIQavg h-index

University of Gdańsk has an average h-index of 60.6 in OpenAlex.

What is the ROR of University of Gdańsk?

ScholarIQror

The ROR for University of Gdańsk is on the source record.

What is the OpenAlex record for University of Gdańsk?

ScholarIQopenalex

The OpenAlex for University of Gdańsk is on the source record.

Who are the most-cited researchers behind University of Gdańsk?

ScholarIQtop researchers by citations
1
Paweł Horodecki · Quantum Mechanics and Applications
331 works32,461 citations
2
Michał Horodecki · Quantum Information and Cryptography
284 works32,376 citations
3
Ryszard Horodecki · Quantum Mechanics and Applications
143 works23,079 citations
4
Rafał Dziadziuszko · Lung Cancer Treatments and Mutations
603 works18,905 citations
5
Piotr Stepnowski · Pharmaceutical and Antibiotic Environmental Impacts
423 works17,491 citations

What are the most-cited papers on University of Gdańsk?

ScholarIQmost cited works
Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer
Solange Peters, D. Ross Camidge, Alice T. Shaw, Shirish M. Gadgeel, Jin Seok Ahn, Dong‐Wan Kim, Sai‐Hong Ignatius Ou, M. Pérol, Rafał Dziadziuszko, Rafael Rosell, Ali Zeaiter, Emmanuel Mitry, Sophie Golding, Bogdana Balas, Johannes Noé, Peter N. Morcos, Tony Mok
New England Journal of Medicine. 20172,489 CitationsOPEN ACCESS
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study
Tony Mok, D. Ross Camidge, Shirish M. Gadgeel, Rafael Rosell, Rafał Dziadziuszko, D.-W. Kim, M. Pérol, S.-H.I. Ou, Jin Seok Ahn, A. Shaw, Walter Bordogna, Vlatka Smoljanović, Magalie Hilton, Thorsten Ruf, Johannes Noé, Solange Peters
Annals of Oncology. 2020699 CitationsOPEN ACCESS
Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer
Lecia V. Sequist, Jean‐Charles Soria, Jonathan W. Goldman, Heather A. Wakelee, Shirish M. Gadgeel, Andréa Varga, Vassiliki A. Papadimitrakopoulou, Benjamin Solomon, Geoffrey R. Oxnard, Rafał Dziadziuszko, Dara L. Aisner, Robert C. Doebele, Cathy Galasso, Edward B. Garon, Rebecca S. Heist, Jennifer Logan, Joel W. Neal, Melody Mendenhall, Suzanne Nichols, Zofia Piotrowska, Antoinette J. Wozniak, Mitch Raponi, Chris Karlovich, Sarah Jaw‐Tsai, Jeffrey D. Isaacson, Darrin Despain, Shannon Matheny, Lindsey Rolfe, Andrew R. Allen, D. Ross Camidge
New England Journal of Medicine. 2015665 CitationsOPEN ACCESS
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
Christian Rolfo, Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlési, Trever G. Bivona, Maximilian Diehn, Caroline Dive, Rafał Dziadziuszko, Natasha B. Leighl, Umberto Malapelle, Tony Mok, Nir Peled, Luis E. Raez, Lecia V. Sequist, Lynette M. Sholl, Charles Swanton, Chris Abbosh, Daniel S.W. Tan, Heather A. Wakelee, Ignacio I. Wistuba, Rebecca A. Bunn, Janet Freeman‐Daily, Murry W. Wynes, Chandra P. Belani, Tetsuya Mitsudomi, David R. Gandara
Journal of Thoracic Oncology. 2021665 CitationsOPEN ACCESS
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
Alexander Drilon, Salvatore Siena, Rafał Dziadziuszko, Fabrice Barlési, Matthew Krebs, Alice T. Shaw, Filippo de Braud, Christian Rolfo, Myung‐Ju Ahn, Jürgen Wolf, Takashi Seto, Byoung Chul Cho, Manish R. Patel, Chao‐Hua Chiu, Thomas John, Kōichi Goto, Christos S. Karapetis, Hendrick-Tobias Arkenau, Sang-We Kim, Yuichiro Ohe, Yu Li, Young Kwang Chae, Christine H. Chung, Gregory A. Otterson, Haruyasu Murakami, Chia‐Chi Lin, Daniel Shao-Weng Tan, Hans Prenen, Todd Riehl, Edna Chow‐Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R. Wilson, Robert C. Doebele
The Lancet Oncology. 2019544 CitationsOPEN ACCESS

How much of the research on University of Gdańsk is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
40%
Hybrid
10%
Bronze
50%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial